SCHEMBL7376756

SCHEMBL7376756

COc1cc2c(cc1OCc1ccccc1)C(=O)OC(O)(C(=O)O)C2c1cc(OC)c(OC)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.43
PDE4A P27815 2/20 0.41
PDE4B Q07343 2/20 0.41
PDE4C Q08493 2/20 0.41
PDE4D Q08499 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
APP P05067 1/20 0.40
MAPT P10636 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
ABCB1 P08183 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
SRD5A1 P18405 2/20 0.39
SRD5A2 P31213 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7380788 0.89 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL7382926 0.88 BCHE (0.43) AKR1B1PDE4APDE4BPDE4CPDE4D
SCHEMBL7385552 0.87 ALDH1A1 (0.53) AKR1B1PDE4DALDH1A1SMN1; SMN2KDM4E
SCHEMBL7385028 0.85 AKR1B1 (0.43) AKR1B1SIRT2ALDH1A1SMN1; SMN2KDM4E
SCHEMBL7383655 0.83 BCHE (0.40) AKR1B1PDE4APDE4BPDE4CPDE4D
SCHEMBL7387564 0.82 MAPK1 (0.41) ALDH1A1SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL7381140 0.82 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2KDM4EMAPTHSD17B10
SCHEMBL7386545 0.80 TOP1 (0.39) KDM4EMAPT
SCHEMBL7383785 0.80 TOP1 (0.39) KDM4EMAPT
SCHEMBL7384620 0.80 MAPT (0.39) ALDH1A1SMN1; SMN2KDM4EMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486155-B1 Method of inhibiting neoplastic cells with isoquinoline derivatives CELL PATHWAYS INC 2002-11-26 US disclosed
WO-1998038168-A1 ISOQUINOLINONE DERIVATIVES, PROCESS FOR PREPARING THE SAME, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS TANABE SEIYAKU CO., LTD. (JP) 1998-09-03 WO disclosed